Enbrel and Pleurisy - a phase IV clinical study of FDA data

Summary:

We study 633,316 people who have side effects when taking Enbrel. Pleurisy is found, especially among people who are female, 60+ old, have been taking the drug for 1 - 6 months, also take Methotrexate and have Psoriatic arthropathy.

The phase IV clinical study analyzes which people take Enbrel and have Pleurisy. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

What are phase IV trials?

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jul, 21, 2023

633,316 people reported to have side effects when taking Enbrel.
Among them, 382 people (0.06%) have Pleurisy.

What is Enbrel?

Enbrel has active ingredients of etanercept. It is used in rheumatoid arthritis. Currently, eHealthMe is studying from 654,018 Enbrel users.

What is Pleurisy?

Pleurisy (inflammation of the pleurae, which causes pain when breathing) is found to be associated with 1,752 drugs and 1,114 conditions by eHealthMe. Currently, we are studying 8,782 people who have Pleurisy.

Number of Enbrel and Pleurisy reports submitted per year:

* Approximation only. Some reports may have incomplete information.

Do you take Enbrel and have Pleurisy?

Check whether Pleurisy is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Pleurisy and when was it recovered:

Pleurisy in Enbrel

Expand to all the drugs that have ingredients of etanercept:

Pleurisy and drugs with ingredients of etanercept (419 reports)

Alternative drugs to, pros and cons of Enbrel:

Enbrel (654,018 reports)

Browse all side effects of Enbrel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Pleurisy treatments and more:

Pleurisy (8,782 reports)

Common drugs associated with Pleurisy:

All the drugs that are associated with Pleurisy:

Pleurisy (1,752 drugs)

Common conditions associated with Pleurisy:

All the conditions that are associated with Pleurisy:

Pleurisy (1,114 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on etanercept (the active ingredients of Enbrel) and Enbrel (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.